A F J E Vrancken
Overview
Explore the profile of A F J E Vrancken including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
190
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wiersma M, van der Star G, Notermans N, van Doorn P, Vrancken A
J Peripher Nerv Syst
. 2024 Oct;
29(4):383-392.
PMID: 39473054
The prevalence of chronic polyneuropathy will increase due to the aging population, and therefore, it becomes ever so important to optimize the diagnostic process. However, it is uncertain which blood...
2.
Kuitwaard K, Brusse E, Jacobs B, Vrancken A, Eftimov F, Notermans N, et al.
Eur J Neurol
. 2020 Sep;
28(1):286-296.
PMID: 32876962
Background And Purpose: High peak serum immunoglobulin G (IgG) levels may not be needed for maintenance intravenous immunoglobulin (IVIg) treatment in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and such high levels...
3.
Goedee H, Jongbloed B, van Asseldonk J, Hendrikse J, Vrancken A, Franssen H, et al.
Eur J Neurol
. 2017 Aug;
24(10):1307-1313.
PMID: 28762574
Background And Purpose: To compare the performance of neuroimaging techniques, i.e. high-resolution ultrasound (HRUS) and magnetic resonance imaging (MRI), when applied to the brachial plexus, as part of the diagnostic...
4.
Dlamini N, Voermans N, Lillis S, Stewart K, Kamsteeg E, Drost G, et al.
Neuromuscul Disord
. 2013 May;
23(7):540-8.
PMID: 23628358
Mutations in the skeletal muscle ryanodine receptor (RYR1) gene are a common cause of neuromuscular disease, ranging from various congenital myopathies to the malignant hyperthermia (MH) susceptibility trait without associated...
5.
Stork A, Notermans N, Vrancken A, van den Berg L, van der Pol W
Neurology
. 2011 Dec;
77(17):e102-3.
PMID: 22135814
No abstract available.
6.
Collins M, Dyck P, Gronseth G, Guillevin L, Hadden R, Heuss D, et al.
J Peripher Nerv Syst
. 2010 Nov;
15(3):176-84.
PMID: 21040139
Non-systemic vasculitic neuropathy (NSVN) is routinely considered in the differential diagnosis of progressive axonal neuropathies, especially those with asymmetric or multifocal features. Diagnostic criteria for vasculitic neuropathy, classification criteria for...
7.
Vrancken A, Gathier C, Cats E, Notermans N, Collins M
Eur J Neurol
. 2010 May;
18(1):49-58.
PMID: 20482601
Background: vasculitic neuropathy can be confirmed by demonstrating vasculitis in a nerve biopsy, but it is uncertain to what extent combined (i.e. nerve/muscle) biopsy improves the yield. Methods: a random-effects...
8.
Vrancken A, Notermans N, Wokke J, Franssen H
J Neurol
. 2008 Aug;
255(8):1127-35.
PMID: 18719962
Objective: To assess the realistic yield of lower leg sensory nerve action potential amplitudes (SNAP) and the sural/radial nerve amplitude ratio (SRAR) in the routine evaluation of suspected distal axonal...
9.
Vrancken A, Hughes R, Said G, Wokke J, Notermans N
Cochrane Database Syst Rev
. 2007 Jan;
(1):CD006050.
PMID: 17253577
Background: Non-systemic vasculitic neuropathy is a rare disabling disease that usually has a subacute onset of progressive or relapsing-remitting sensory or sensorimotor deficits. Asymmetry, pain and weakness are key features....
10.
Vrancken A, Kalmijn S, Buskens E, Franssen H, Vermeulen M, Wokke J, et al.
J Neurol Neurosurg Psychiatry
. 2006 Feb;
77(3):397-401.
PMID: 16484653
Background: Extensive investigations are often performed to reveal the cause of chronic polyneuropathy. It is not known whether a restrictive diagnostic guideline improves cost efficiency without loss of diagnostic reliability....